The new company aims to combine with a business in the life sciences industry. Brookline Capital is led by Chairman and CEO Dr. Samuel P. Wertheimer, President Scott A. Katzmann, and CFO Patrick A. Sturgeon.
Total SPAC deal count for 2021 year-to-date is now 85 with $23.655 billion in gross proceeds raised. This offering is expected to close on Tuesday, February 2.
Ladenburg Thalmann is acting as sole book-running manager for the offering. Ellenoff Grossman & Schole LLP is serving as Issuer’s Counsel with Graubard Miller serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.